Prilosec OTC “Coverage Gap” Pitch Spotlights Medicare Payment Question
This article was originally published in The Tan Sheet
Executive Summary
An initiative promoting Prilosec OTC over prescription competitors to help Medicare Part D users avoid "the coverage gap" in their prescription costs may prompt a closer look at ways Medicare can pay for OTCs
You may also be interested in...
Perrigo Pursues OTC Reimbursement Opportunity In Emerging "ORx" Space
Perrigo has entered a nascent growth channel by pursuing reimbursement for OTC drugs prescribed by doctors and dispensed by pharmacists
Perrigo Pursues OTC Reimbursement Opportunity In Emerging "ORx" Space
Perrigo has entered a nascent growth channel by pursuing reimbursement for OTC drugs prescribed by doctors and dispensed by pharmacists
Perrigo Pursues OTC Reimbursement Opportunity In Emerging "ORx" Space
Perrigo has entered a nascent growth channel by pursuing reimbursement for OTC drugs prescribed by doctors and dispensed by pharmacists